The Latest Cardiac and Vascular News
FORT LAUDERDALE, Fla., March 20, 2025 /PRNewswire/ — Discover the groundbreaking work of Starlight Cardiovascular, a company dedicated to creating life-saving technologies for children with congenital heart disease, a condition affecting countless families nationwide. Starlight…
Award supports design and preclinical testing of Pulmonary Flow Restrictor for Congenital Heart Disease SAN DIEGO, May 1, 2024 /PRNewswire/ — Starlight Cardiovascular, Inc., a company developing pediatric cardiovascular medical devices, announced that it has been awarded a Small Business…
Company developing a cardiovascular medical device portfolio for underserved pediatric population SAN DIEGO, June 13, 2023 /PRNewswire/ — Paul G. Yock has joined the Starlight Cardiovascular Board of Directors. Dr. Yock is the Founder, Director Emeritus, and a Board Member of the Stanford Byers Center for Biodesign. He is the former Martha Meier Weiland […]
Award supports design and preclinical testing of pediatric stent SAN DIEGO, March 22, 2023 /PRNewswire/ — Starlight Cardiovascular, Inc., a medical device company developing pediatric cardiovascular devices, announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Heart, Lung, and Blood Institute (NHLBI) of […]
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices. The financing is led by Bird B and included conversion of previously-issued notes. “Congenital Heart Defects are […]
